Pardes Biosciences, Inc.
PRDSDelisted Aug 31, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001822711
Pardes Biosciences, Inc. was delisted on Aug 31, 2023; its insiders filed their last Form 4 on Aug 31, 2023; 59 institutions reported holding it in 13F filings for Q2 2023, worth $63.9M in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding Pardes Biosciences, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 67 | 2 | 64 | −1 |
| Shares | 47.2M | 5.23M | 37.8M | −4.16M (−9.9%) |
| Value | $87.2M | $9.67M | $63.8M | −$13.7M (−17.7%) |
2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (11)
Institutions that held Pardes Biosciences, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BML Capital Management, LLC | 4,867,984 | $8.23M | 7.86% |
| Soleus Capital Management, L.P. | 1,250,000 | $2.11M | 0.30% |
| Walleye Capital LLC | 266,782 | $450.9K | 0.01% |
| SVB Financial Group | 77,880 | $131.9K | 0.36% |
| Renaissance Technologies LLC | 29,886 | $51.0K | 0.00% |
| MBB Public Markets I LLC | 30,000 | $50.7K | 0.00% |
| Jane Street Group, LLC | 21,473 | $36.3K | 0.00% |
| Tri Locum Partners LP | 19,757 | $33.0K | 0.01% |
| Chicago Partners Investment Group LLC | 11,316 | $21.3K | 0.00% |
| Advisor Group Holdings, Inc. | 1,000 | $1.69K | 0.00% |
| Nisa Investment Advisors, LLC | 138 | $0 | 0.00% |
Sold out (12)
Institutions that held Pardes Biosciences, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Ra Capital Management, L.P. | 6,175,038 | $11.4M |
| Frazier Life Sciences Management, L.P. | 845,636 | $1.56M |
| Price T Rowe Associates Inc | 753,595 | $1.40M |
| PFM Health Sciences, LP | 285,170 | $528.0K |
| Altai Capital Management, L.P. | 82,097 | $152.0K |
| Manufacturers Life Insurance Company, The | 44,071 | $87.6K |
| TD Asset Management Inc | 26,500 | $53.0K |
| Virtu Financial LLC | 13,376 | $25.0K |
| Voya Investment Management LLC | 13,329 | $24.7K |
| Susquehanna International Group, LLP | 10,535 | $19.0K |
| Capital Advisors, Ltd. LLC | 151 | $0 |
| State of Wyoming | 50 | $0 |
Not filed for Q4 2022 yet (2)
Institutions that held Pardes Biosciences, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Foresite Capital Opportunity Management V, LLC | 5,227,307 | $9.67M |
| American Portfolios Advisors | 1,000 | $1.85K |